Abstract:This study highlights the successful development of spatiotemporal theranostic nanoprobes, whose emission wavelength successfully redshifts to the same as that of indocyanine green after the self‐assembly of dasatinib dimers, thus improving the total fluorescence intensity. They also exhibit dynamic fluorescence intensity conversions at the tumor site, therefore achieving precise tumor diagnosis, spatiotemporal tracing of drug fate, and prognosis evaluation. Currently, spatiotemporal theranostic nanoprobes are in great demand, owing to their enhanced target therapy and precise dynamic tracing of in vivo drug fate. Herein, this study highlights the successful development of dynamic theranostic nanoprobes, which are facilely established via self‐assembly between glutathione (GSH)‐responsive dasatinib (DAS) dimers and indocyanine green (ICG). The DAS dimers endow the nanoprobes with aggregation‐induced emission (AIE) characteristic, whose emission wavelength successfully redshifts from 420 to 810 nm compared to DAS‐based nanoprobes, the same as that of ICG, thus improving the total fluorescence intensity. Moreover, the nanoprobes exhibit a dynamic fluorescence intensity conversion that first decreases and then increases at the tumor site via intracellular GSH‐triggered AIE quenching and fluorescence re‐enhancement of ICG, therefore achieving precise tumor diagnosis, prognosis evaluation, and spatiotemporal tracing of drug fate compared to other imaging strategies. Furthermore, the nanoprobes show long‐term circulation stability via suitable particle sizes and zeta potentials, improved tumor accumulation via extracellular protonation and active cellular uptake, efficient drug release via response to the intracellular milieu, and enhanced apoptosis via targeting to intracellular kinase, therefore achieving the significant tumor inhibition. Thus, the spatiotemporal theranostic nanoprobes can dynamically monitor the targeted tumor therapy, greatly advancing their application in clinics.

Pre-blocked Molecular Shuttle As an In-Situ Real-Time Theranostics.

Supramolecular Nano-Tracker for Real-Time Tracking of Drug Release and Efficient Combination Therapy

Engineering Molecular Self-Assembly of Theranostic Nanoprobes for Dual-Modal Imaging-Guided Precise Chemotherapy

A unimolecular theranostic system with H<sub>2</sub>O<sub>2</sub>-specific response and AIE-activity for doxorubicin releasing and real-time tracking in living cells

Co-delivery of Cu(I) Chelator and Chemotherapeutics As a New Strategy for Tumor Theranostic.

A Targeting Theranostics Nanomedicine As an Alternative Approach for Hyperthermia Perfusion.

Tumor-marker-mediated "On-Demand" Drug Release and Real-Time Monitoring System Based on Multifunctional Mesoporous Silica Nanoparticles.

Super-resolution imaging for in situ monitoring sub-cellular micro-dynamics of small molecule drug

Redox-Activated Light-Up Nanomicelle for Precise Imaging-Guided Cancer Therapy and Real-Time Pharmacokinetic Monitoring

Supramolecular prodrug-like nanotheranostics with dynamic and activatable nature for synergistic photothermal immunotherapy of metastatic cancer

A Polyplatin with Hands-Holding Near-Infrared-II Fluorophores and Prodrugs at a Precise Ratio for Tracking Drug Fate with Realtime Readout and Treatment Feedback

A Nanostrategy for Efficient Imaging‐Guided Antitumor Therapy through a Stimuli‐Responsive Branched Polymeric Prodrug

Polyrotaxane-based Supramolecular Theranostics

A Novel Theranostic Nanoprobe for in Vivo Singlet Oxygen Detection and Real-Time Dose-Effect Relationship Monitoring in Photodynamic Therapy

Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics

Endogenous MicroRNA-Triggered and Real-Time Monitored Drug Release Via Cascaded Energy Transfer Payloads

Supramolecular Engineering of Polymeric Nanodrugs for Antitumor Chemotherapy

Rational Design of High Performance Nanotheranostics for NIR-II Fluorescence/magnetic Resonance Imaging Guided Enhanced Phototherapy.

A Redox-Activated Theranostic Nanoagent: Toward Multi-Mode Imaging Guided Chemo-Photothermal Therapy

Programmable Ultrasound Imaging Guided Theranostic Nanodroplet Destruction for Precision Therapy of Breast Cancer

Spatiotemporal Theranostic Nanoprobes Dynamically Monitor Targeted Tumor Therapy